A phase 3 study to determine the efficacy and safety of lenalidomide combined with melphalan and prednisone in patients > 65 years with newly diagnosed multiple myeloma (NDMM)
https://www.powershow.com/view4/680fea-NjVhM/A_phase_3_study_to_determine_the_efficacy_and_safety_of_lenalidomide_combined_with_melphalan_and_prednisone_in_patients_65_years_with_newly_diagnosed_multiple_myeloma_NDMM_powerpoint_ppt_presentation
Icons create by Freepik from www.flaticon.com/